Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.
Klimentova M, Shelikhova L, Ilushina M, Kozlovskaya S, Blagov S, Popov A, Kashpor S, Fadeeva M, Olshanskaya J, Glushkova S, Pershin D, Balashov D, Maschan A, Maschan M.
Klimentova M, et al.
Transplant Cell Ther. 2023 Feb;29(2):127.e1-127.e9. doi: 10.1016/j.jtct.2022.11.022. Epub 2022 Nov 25.
Transplant Cell Ther. 2023.
PMID: 36436779
Free article.
Clinical Trial.